Core Scientific (NASDAQ:CORZ) Insider Todd Duchene Sells 10,000 Shares

Key Points

• Todd Duchene sold 10,000 Core Scientific shares on May 4 at an average price of $20.86 for $208,600, leaving him with 1,980,348 shares (about a 0.50% reduction).
• Shares rallied (~11%) amid a announced ~$421M Polaris DS acquisition and plans to expand the Muskogee campus to ~1.5 GW, which alongside heavy call buying has driven bullish sentiment and analyst attention.
• The company posted a sharp Q1 earnings miss—EPS $(1.06) vs. consensus $(0.02) and revenue $115.24M vs. $117.04M expected—raising near‑term profitability and execution concerns despite the strategic growth push.

Core Scientific, Inc. (NASDAQ:CORZ - Get Free Report) insider Todd Duchene sold 10,000 shares of the firm's stock in a transaction on Monday, May 4th. The shares were sold at an average price of $20.86, for a total value of $208,600.00. Following the completion of the transaction, the insider owned 1,980,348 shares of the company's stock, valued at approximately $41,310,059.28. This represents a 0.50% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Get Core Scientific SMS alerts:

Sign Up

Core Scientific Trading Up 11.0%

Shares of CORZ stock traded up $2.44 during mid-day trading on Wednesday, reaching $24.63. The stock had a trading volume of 39,169,850 shares, compared to its average volume of 12,494,860. Core Scientific, Inc. has a 12-month low of $8.74 and a 12-month high of $25.01. The company has a market cap of $7.77 billion, a P/E ratio of 21.05 and a beta of 5.45. The business has a 50-day simple moving average of $17.51 and a 200 day simple moving average of $17.43.

Core Scientific (NASDAQ:CORZ - Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported ($1.06) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by ($1.04). The company had revenue of $115.24 million during the quarter, compared to analysts' expectations of $117.04 million. Research analysts anticipate that Core Scientific, Inc. will post 0.07 EPS for the current year.

Key Stories Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Announced acquisition of Polaris DS LLC (~$421M plus up to $40M contingent) that adds adjacent land, an on‑site substation and roughly 440 MW of contracted gross power — accelerates Core’s ability to scale Muskogee to ~1.5 GW and serve AI/HPC customers. Core Scientific jumps after announcing $421M Polaris DS acquisition
• Positive Sentiment: Company outlined a multi‑tiered plan to expand the Muskogee campus to ~1.5 GW gross (~1.0 GW leasable), signaling a big addressable pipeline for high‑density colocation demand. This supports long‑term revenue upside tied to AI/HPC capacity. Core Scientific Plans Expansion to 1.5 Gigawatts
• Positive Sentiment: Media coverage framing the Muskogee plan as a gigawatt‑scale buildout pushed sentiment and visibility, helping drive buying interest. CORZ stock soars to record high on Oklahoma data center plan
• Positive Sentiment: Unusual options activity: heavy call buying (roughly 196k calls) indicates speculative/bullish positioning that can amplify intraday upside as traders chase momentum.
• Neutral Sentiment: Institutional and analyst interest: recent 13F moves and several price targets in the mid‑$20s (median ~$25) show growing analyst/institutional exposure, which can support the stock if execution continues.
• Neutral Sentiment: Corporate update: appointment of Jorge Ray as Principal Accounting Officer (governance/ops update; not material to near‑term revenue). Core Scientific Appoints Jorge Ray Principal Accounting Officer
• Negative Sentiment: Q1 earnings miss: reported EPS of ($1.06) vs. consensus ($0.02) and revenue of $115.24M vs. $117.04M est. The sizable EPS shortfall is a near‑term negative on profitability and raises execution/earnings‑quality questions. Core Scientific Q1 Press Release / Slide Deck

Wall Street Analysts Forecast Growth

CORZ has been the subject of a number of recent research reports. Canaccord Genuity Group lifted their price objective on Core Scientific from $17.00 to $20.00 and gave the stock a "buy" rating in a research report on Wednesday, March 4th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Core Scientific in a research report on Monday, April 20th. Wall Street Zen upgraded Core Scientific to a "sell" rating in a research report on Saturday, March 14th. Keefe, Bruyette & Woods lifted their price objective on Core Scientific from $19.00 to $25.00 and gave the stock a "moderate buy" rating in a research report on Tuesday, January 27th. Finally, Needham & Company LLC upgraded Core Scientific from a "hold" rating to a "buy" rating and set a $23.00 price objective for the company in a research report on Tuesday, March 3rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $25.07.

Institutional Trading of Core Scientific

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Allworth Financial LP grew its holdings in Core Scientific by 206.5% in the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company's stock valued at $25,000 after buying an additional 950 shares during the period. Larson Financial Group LLC grew its holdings in Core Scientific by 936.7% in the 4th quarter. Larson Financial Group LLC now owns 1,866 shares of the company's stock valued at $27,000 after buying an additional 1,686 shares during the period. Osaic Holdings Inc. grew its holdings in Core Scientific by 112.1% in the 2nd quarter. Osaic Holdings Inc. now owns 2,017 shares of the company's stock valued at $34,000 after buying an additional 1,066 shares during the period. Danske Bank A S purchased a new stake in Core Scientific in the 4th quarter valued at about $36,000. Finally, State of Wyoming purchased a new stake in Core Scientific in the 4th quarter valued at about $66,000.

About Core Scientific

Core Scientific, Inc NASDAQ: CORZ is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific's service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.